Angioplasty Balloons Market By Product Type (Normal Ballons, Cutting Ballons, Drug-Eluting Ballons), Application (Coronary Angioplasty, Peripheral Angioplasty), End-Users (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories), & Region for 2024-2031

Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Angioplasty Balloons Market By Product Type (Normal Ballons, Cutting Ballons, Drug-Eluting Ballons), Application (Coronary Angioplasty, Peripheral Angioplasty), End-Users (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories), & Region for 2024-2031

Angioplasty Balloons Market Valuation – 2024-2031

The increasing geriatric population and cardiovascular diseases (CVDs) are becoming more prevalent among the elderly due to age-related factors such as diminished blood channel flexibility and increasing plaque formation. For instance, according to the geriatric population in 2022 globally was estimated to be 1.4 billion. This demographic shift towards an older population has increased demand for minimally invasive procedures and angioplasty balloons. Thus, the increasing geriatric population is driving the market size to surpass USD 2.05 Billion in 2024 to reach a valuation of around USD 2.62 Billion by 2031.

Increasing public awareness of cardiovascular diseases (CVDs) and the availability of minimally invasive treatment alternatives, such as angioplasty, are key factors propelling the industry’s growth. As more people become aware of the dangers and symptoms associated with CVDs, there is a greater emphasis on obtaining prompt medical assistance for diagnosis and treatment. The increasing awareness of CVD and minimally invasive procedures is enabling the market to grow at a CAGR of 3.43% from 2024 to 2031.

Angioplasty Balloons MarketDefinition/ Overview

Angioplasty balloons are small, inflatable medical devices utilized in a minimally invasive procedure known as angioplasty, aimed at widening narrowed or blocked arteries. The Balloon Angioplasty with the Distal Protection of Stent Retriever (BASIS) technique is a revolutionary thrombectomy approach that allows for emergent balloon angioplasty via the retrieval stent’s wire. Balloon angioplasty is performed, in some clinical scenarios of stent implantation retrieval stent placement, passage of aspiration catheter following after balloon deflated, retrieval stent re-placement, and withdrawal of the retrieval stent, balloon angioplasty via wire of retrieval stent, negative aspiration, and revascularization.

Angioplasty balloons are like tiny lifesavers for clogged arteries. They're inserted through a small tube and then inflated to open up the blockages, letting blood flow freely again. Compared to traditional open-heart surgery, angioplasty is a game-changer. It's less painful, has a shorter recovery time, and carries a lower risk of complications. It's also a more patient-friendly approach. As balloon technology advances, angioplasty is becoming even more versatile. There are now balloons that release medication to prevent blockages from reoccurring and balloons with cutting edges to remove plaque more effectively. With the growing number of people suffering from heart disease and the increasing preference for less invasive treatments, angioplasty balloons are playing a vital role in revolutionizing cardiovascular care.

As technology advances, angioplasty balloons will undoubtedly remain a game changer in interventional cardiology, promising a brighter future for cardiovascular health on a worldwide scale. After balloon angioplasty of the stenotic location, the risk of aspiration catheters passing through the occlusion site increases. Balloon angioplasty should be performed with caution if the stenotic lesion covers the perforators of the penetrating artery, such as the lenticulostriate or pontine perforating arteries.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How the Increasing Prevalence of Cardiovascular Diseases is Driving the Growth of Angioplasty Balloons Market?

The increasing prevalence of cardiovascular diseases is fueling the demand for the angioplasty balloons market. A burgeoning population faces increased risks of cardiovascular diseases (CVDs) due to factors such as poor lifestyles, aging populations, and rising diabetes rates. For instance, according to the report, in the United States in 2021, around 695,000 people died due to heat disease and every 33 seconds one patient died due to CVD. This demographic trend highlights a growing desire for minimally invasive procedures such as angioplasty, in which balloons are critical tools for expanding clogged arteries.

The prevalence of unhealthy lifestyles, such as sedentary habits, poor dietary choices, and tobacco use, contributes considerably to the rising incidence of CVD worldwide. In addition, as the population ages, the prevalence of age-related risk factors such as hypertension and atherosclerosis increases, adding to the burden of CVDs. Furthermore, the rising incidence of diabetes, particularly type 2 diabetes, heightens the risk of cardiovascular problems, demanding prompt measures to avoid negative outcomes.

As healthcare challenges continue to change, less invasive procedures like angioplasty have become the preferred go-to for treatment. Angioplasty involves threading tiny balloons into narrowed or blocked arteries and inflating them to widen the blood vessels and restore healthy blood flow. Compared to traditional surgery, angioplasty has several perks that make it more appealing to patients. For starters, the recovery time is shorter, the chance of complications is lower, and overall patient outcomes are better. Plus, unlike open-heart surgery, angioplasty is minimally invasive, which means it's less painful after the procedure, and patients recover quicker. This focus on what's best for the patient has led to a clear preference for balloon angioplasty surgeries. It's a less invasive method with a shorter recovery time and a lower risk of complications—a win-win for everyone involved.

Imagine a procedure that could fix your heart problems without major surgery and a lengthy recovery. That's what balloon angioplasty is all about! Unlike traditional open-heart surgery, angioplasty uses a tiny balloon to widen narrowed arteries in your heart. It's a gentle and less invasive approach, so there's less pain and a faster recovery. The risks are also lower with angioplasty, which means a better outcome for you. It's no wonder that both doctors and patients are choosing balloon angioplasty over surgery. This procedure can help people with various heart conditions, from blocked arteries to narrowed veins. It's a major advancement in cardiology, allowing us to treat heart problems with less hassle and discomfort. So, if you need heart treatment, ask your doctor if balloon angioplasty is right for you. It's a safe, effective, and patient-friendly way to get your heart back in tip-top shape.

How the Risk of Angioplasty Balloons in the Bypass Surgery is Hampering the Growth of the Angioplasty Balloons Market?

In circumstances where arteries are significantly narrowed or hardened due to calcification, angioplasty balloons alone may not be enough to dilate the vessels adequately. It is critical to understand that angioplasty balloons may not be appropriate for all people or types of blockages. Severe occlusions or complex lesions may provide difficulties during angioplasty, potentially leading to poor results or procedural consequences. As a result, healthcare providers must carefully evaluate the severity and complexity of each patient’s disease to identify the best treatment strategy.

Despite their minimum invasiveness, angioplasty balloons may face competition from even less invasive treatment modalities such as medication management or upcoming technologies that are still in the development stage. The changing landscape of cardiovascular therapy options can have a substantial impact on market dynamics.

While balloon angioplasty has proven effective in expanding restricted arteries and restoring blood flow, the introduction of alternative techniques such as pharmaceutical therapies presents a problem. Medication management techniques, such as the use of antiplatelet medicines, statins, and blood pressure drugs, provide non-invasive ways to control cardiovascular disease. Furthermore, advances in medical technology continue to promote the development of novel treatments, such as drug-coated balloons or bioresorbable stents, intending to further reduce the invasiveness of cardiovascular procedures.

Balloon angioplasty requires well-equipped catheterization laboratories with well-trained Staff. The limited access to such facilities especially in remote areas, poses significant challenges and restricts patients’ access to these lifesaving procedures. Many localities, particularly rural or physically remote areas, may have limited or no access to catheterization labs. Patients in these places may experience difficulties in prompt cardiovascular therapy, such as balloon angioplasty, due to a lack of close facilities.

Category-Wise Acumens

How the Increasing Prevalence of Peripheral Artery Diseases is Driving Demand for Cutting Balloons Segment in the Angioplasty Balloons Market?

When it comes to opening up clogged blood vessels, cutting balloons are taking over the market. That's because more and more people are getting two serious conditionsperipheral artery disease (PAD) and coronary artery disease (CAD). Both of these conditions block arteries, which can lead to serious health problems like heart attacks and strokes. Doctors need better ways to fix these clogged arteries, and cutting balloons are stepping up to the plate. They're like regular angioplasty balloons, but they have tiny blades that score the plaque inside the arteries. This makes it easier to remove the plaque and open up the artery, which keeps the blood flowing better. Plus, cutting balloons are less likely to tear the artery or cause it to shrink back down. That means better results and lower risks for patients. So, it's no surprise that doctors are ditching the old balloons and cutting loose with cutting balloons.

Hey there! Exciting advancements in balloon technology have made it easier to place and expand stents in arteries. These special "scoring balloons" work great with drug-filled stents to make sure they open up just enough in the right spot. This teamwork boosts the effectiveness of stent treatments and improves the long-term health of patients with leg or heart artery problems. Plus, the development of specialty balloons, like the AngioSculpt and Flextome, is getting a lot of attention from big companies. These nifty tools have been approved in important markets like the US, Europe, and Japan. With these products now widely available, they're expected to become even more popular in the coming years.

DEBs’ advantages, including as their capacity to administer medication directly to the site of artery illness, resulting in lower restenosis rates and better long-term outcomes, contribute to their increasing appeal among healthcare practitioners and consumers. Furthermore, DEBs’ lower cost compared to stents makes them an appealing option for healthcare organizations aiming to optimize cost-effectiveness while maintaining high-quality care standards.

Heart problems are on the rise, especially blockages in the arteries that carry blood to the heart. This is a big worry because it shows how badly we need better ways to treat coronary artery disease. This disease happens when these arteries get narrower or clogged, making it harder for blood to get to the heart muscle. It's a big problem around the world, and things like not getting enough exercise, eating poorly, and getting older are all making it worse. Because of this, there's a growing need for treatments that can help with coronary artery disease and make it less harmful to people's health and happiness.

The strong rise of the coronary artery disease segment can be due to a greater emphasis on preventative healthcare, early detection, and enhanced treatment options. Healthcare practitioners are increasingly prioritizing procedures including angioplasty, stenting, and coronary artery bypass surgery to relieve symptoms, enhance heart function, and lower the risk of life-threatening consequences from coronary artery disease.

Gain Access to Angioplasty Balloons Market Report Methodology

Country/Region-wise Acumens

How the Advanced Technology and Presence of Key Players in the Region are Fostering the Growth of North America in the Angioplasty Balloons Market?

When big names in healthcare set up shop in your backyard, it's a game-changer for the industry. These giants bring decades of expertise, deep pockets, and the latest and greatest technology. They use this arsenal to push the boundaries of cardiovascular medicine, developing cutting-edge treatments that save lives. But it's not just the big players who are shaping the future of cardiovascular care in the region. The government has a big role to play too. Changes in regulations can make it easier or harder for new treatments to reach patients. These twists and turns can shift the competitive landscape, opening the door for new players and shaking things up for the incumbents.

The growing number of percutaneous coronary interventions (PCIs) is a key driver of market growth in the region. PCIs, including procedures such as angioplasty and stent placement, are minimally invasive techniques used to treat coronary artery disease. The increasing prevalence of coronary artery disease and the adoption of PCI procedures as a preferred treatment option contributes to the rising demand for cardiovascular interventions in the region.

How the Increasing Healthcare Investment and Healthcare Infrastructure is Expected to show Growth in the Asia Pacific Angioplasty Balloons Market During the Forecast Period?

Asia Pacific is expected to be the fastest-growing region throughout the forecast period. The cardiovascular intervention market in the region is growing significantly, owing to the rising healthcare spending in the region demonstrates a greater commitment to upgrading healthcare infrastructure and services. This increased investment in healthcare facilities and resources opens the door to breakthroughs in cardiovascular interventions as healthcare providers try to improve patient care and outcomes.

The positive government assistance drives market expansion in the region. Government programs focused on boosting public health and treating cardiovascular illnesses help to drive the development and adoption of new treatments and technology. Policies that prioritize cardiovascular health and direct resources toward preventative measures, early identification, and treatment of heart-related illnesses foster market growth.

Competitive Landscape

The angioplasty balloon market is expected to witness continued growth, driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. Consolidation through mergers and acquisitions might occur as companies strive to strengthen their market positions. Collaboration between established players and emerging companies for technological advancements is also a possibility. The focus will be on developing even more effective, durable, and user-friendly angioplasty balloon solutions to improve patient outcomes and expand access to this life-saving technology.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the angioplasty balloon market include

  • Medtronic
  • Boston Scientific Corporation
  • Johnson & Johnson Services, Inc.
  • Abbott
  • C. R. Bard, Inc.
  • Spectranetics
  • Terumo Medical Corporation
  • Cardinal Health
  • BIOTRONIK
  • Cook
  • ENDOCOR GmbH
  • B. Braun Melsungen AG

Angioplasty Balloons Market Latest Developments

  • In May 2022, Medtronic announced that the low-profile drug-coated balloon platform received U.S. FDA approval to treat Peripheral Arterial Diseases.
  • In March 2021, Medtronic announced the launch of the Chameleon PTA balloon catheter in Germany, Italy, Portugal, South Africa, Spain, and Turkey. The device is suitable for use in native or synthetic arteriovenous dialysis fistulae, as well as femoral, iliac, and renal arteries. The gadget allows for the infusion of diagnostic or therapeutic fluids through an integrated injection point placed near the balloon.
  • In July 2021, Medtronic announced the launch of Prevail Drug Coated Balloon Catheter in Europe. The Prevail DCB is utilized during percutaneous coronary intervention (PCI) operations to treat constricted or blocked coronary arteries in CAD patients.
  • In March 2024, Boston Scientific Corporation, announced that the AGENT Drug-Coated Balloon received the approval of the U.S. FDA. AGENT Drug-Coated Balloon (DCB) treats coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR is defined as the obstruction or narrowing of a stented artery caused by plaque or scar tissue.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2021-2031

Growth Rate

CAGR of ~3.43% from 2024 to 2031

Base Year for Valuation

2024

Historical Period

2021-2023

Forecast Period

2024-2031

Quantitative Units

Value in USD Billion

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • Product Type
  • Application
  • End-Users
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players

Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook, ENDOCOR GmbH, B. Braun Melsungen AG

Customization

Report customization along with purchase available upon request

Angioplasty Balloons Market, By Category

Product Type

  • Normal Ballons
  • Cutting Ballons
  • Drug-Eluting Balloons

Application

  • Coronary Angioplasty
  • Peripheral Angioplasty

End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Catheterization Laboratories

Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

Understanding the Market, Competition, and Your Company's Place We'll give you a thorough breakdown of who your potential customers are, what drives their decisions, and where the market is headed. This includesMarket Size and SegmentsWe'll show you the value of different market segments, breaking them down by economic and lifestyle factors. Growth Projections We'll identify the areas and segments that are expected to expand the fastest and dominate the market. Regional AnalysisWe'll dive into how the market varies from region to region, highlighting trends and factors influencing consumption. Competition You'll get insights into who the key players are, what strategies they're using, and any recent mergers or acquisitions. Your Company's ProfileWe'll create a detailed report on your company, including an overview, strengths and weaknesses, and product comparisons.Looking Ahead and Staying Informed Market Outlook We'll provide our expert opinion on the future direction of the market, including growth drivers, challenges, and opportunities. Porter's Five Forces AnalysisWe'll use this tool to assess the competitive intensity and profitability of the industry. Value Chain Analysis We'll examine the different stages of the industry's supply chain, identifying areas of potential optimization. Market DynamicsWe'll keep you updated on the latest trends and developments that are shaping the industry. Post-Sales Support For six months after your purchase, our analysts will be available for follow-up questions and support.

Customization of the Report

• In case of any <a href="https//www.marketresearch.com/nee

Related Reports

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email